SmallCapInvestor.com
Search
Advanced Search
Quote
Company Search

Independent Small Cap News, Research, and Insights

Home Small Cap News Investing Strategies Industries Stock Research Personal Finance My Stuff
Industries

Thermage CEO expects acquisition to save costs, improve opportunities

Thermage, Inc. (Nasdaq:THRM) CEO Steve Fanning said the company bought Reliant because the two companies, which make anti-aging devices, are complimentary and will allow for greater opportunities through cost savings and an expanded sales force.


AspenBio Pharma shares rise on start of clinical trials

CollaGenex Pharmaceuticals to be acquired by Galderma Laboratories

Merit Medical Systems (MMSI): The heart of the matter

Usana Health Sciences CEO confident about future

Natus Medical Inc.: Hear it first

Genoptix, Inc.: A bone-crusher?

USANA Health Sciences soars on SEC decision

Bio-Imaging Technologies, Inc.: Picture perfect

Hythiam, Inc. to turn CF positive, recorded strong revenues

Sequenom climbs on N.Y. approval of product

Exactech: We age, it grows

Adolor Corp. inks exclusive agreement with Pfizer

Obagi Medical Products, Inc.: Hey, but you look great

AngioDynamics, Inc.: Good for your wealth

Kensey Nash makes first bone void filler shipment

Physicians Formula Holdings reports better-than-expected Q3 earnings

Abiomed slips after wider Q2 loss

Caliper Life Sciences records Q3 loss penny wider than Street's forecast

CryoLife higher as Q3 profit rises

Incyte beats Q3 revenue estimates

Hythiam reports findings from Prometa Treatment Program

Abaxis, Inc.: Catering to both crowds

Sector Watch: Joint replacement

LCA-Vision Q3 revenues shy of Street, lowers guidance

Cardica to initiate secondary offering

Staar Surgical to acquire Canon's interest in JV

Javelin Pharmaceuticals: House of pain relief

Transcend Services books strong quarter

Radiation Therapy Services to be acquired for $1.1B

PetMed Express reports strong Q2 earnings

Angiotech Pharmaceuticals falls to 52-week low, expects Q3 loss

Kensey Nash swings to Q1 loss

Nektar Therapeutics' 'Exubera' dropped by Pfizer

Fonar Corp. receives six orders from Health Diagnostics

Medtox Scientific down after missing Q3 revenue estimates

Via Pharmaceuticals Inc. higher, receives OK for drug tests

Synta Pharmaceuticals to collaborate with GlaxoSmithKline

QLT Inc. falls to 52-week low, buys eye-care company

Cantel Medical CEO: Expansion through acquisitions and internal development

Pre-market: Hansen Medical jumps on Cramer's comments

Generex Biotechnology receives patent for metered dose spray

Hanger Orthopedic Group: On the cutting edge

Javelin Pharmaceuticals granted patent

SIGA Technologies' smallpox drug shows 100% protection

CollaGenex Pharmaceuticals trial for treatment of rosacea fails

Emergent BioSolutions inks $448M contract

Emisphere Technologies settles with Eli Lilly for $18M

Phase 1 trial initiated on Pharmacopeia's drug

Spire Corp. receives order, rises to new 52-week high

Sonus Pharmaceuticals tanks on Phase 3 study failure

Newsletter Watch: Vanity plays

LeMaitre Vascular up after raising FY07 guidance

Volcano Corp. files shelf registration statement with SEC

Misonix narrows Q4 loss

Cardica expands deal with Cook Medical

Possis Medical breaks even in Q4

Somanetics reports increased Q3 profit

Evotec acquires Renovis

Indevus Pharmaceuticals secures U.S. rights to Sanctura

Animal Health International swings to Q4 loss

Micrus Endovascular downgrades revenue guidance

Depomed cuts 25% of it staff

Genta receives FDA OK for its investigational new drug exemption

LCA-Vision: Time to buy?

Synovis Life Technologies: A cure for your portfolio?

Sector Watch: Outsourcing healthcare

Candela Corp. receives FDA clearance on pain reduction device

IRIS International: A medical device maker on the move

Providence Service Corp: Up to the job

Physicians Formula Holdings Inc. closes up on upgrade

Kensey Nash Corp. lower on Q4 loss

Physicians Formula Holdings, Inc. falls on Q2 loss and lackluster outlook

An interview with Gene Marcial

Abiomed: Hearts, and more

Mannatech CEO: legal issues, new sales system focus for rest of year

Syneron Medical Ltd. beats Q2 revenue estimates, raises guidance

Sector Watch: Laparoscopic surgery

Abiomed, Inc receives Canadian regulatory approval for Impella technologies

Vision-Sciences swings to a Q4 profit on gain from sale

Cynosure: More than cosmetic gains

Newsletter Watch: Medical plays

Cantel Medical Corp. says new products and acquisitions will spur growth

Digirad: Condition stabilizing

Thermage reiterates FY07 revenue guidance

Portfolio Update: Systems Xcellence

Capital Senior Living: Where the action is

Emageon stock hits new low on disappointing Q1 results

Physicians Formula shares sink on Q2 outlook

Portfolio Update: Cynosure Inc.

La Jolla up despite wider quarterly loss

Hansen Medical hits new high on FDA nod

Artes Medical: Long-lasting wrinkle correction

Kensey Nash shares down on Q3 results, Q4 outlook

Biolase Technology stock tanks on Q1 guidance